TY - JOUR
T1 - Metastatic merkel cell carcinoma to the thyroid gland
T2 - Case report and review of the literature
AU - Sayeed, Salmaan
AU - Kapustin, Danielle
AU - Rubin, Samuel J.
AU - Fan, Jun
AU - Wiedmer, Christina
AU - Chung, Daniel
AU - Khorsandi, Azita
AU - Brandwein-Weber, Margaret
AU - Friedlander, Philip
AU - Bakst, Richard
AU - Ramirez, Ricardo J.
AU - Urken, Mark L.
N1 - Publisher Copyright:
© 2024 Elsevier Inc.
PY - 2024/7/1
Y1 - 2024/7/1
N2 - Background: Merkel cell carcinoma (MCC) is an aggressive and rare neuroendocrine tumor, accounting for less than 1% of skin cancers. Metastasis primarily manifests in the cervical lymph nodes but rarely affect the thyroid. Methods: We report a case of primary head and neck cutaneous MCC with metastasis to the thyroid gland. A review of the literature of MCC with thyroid metastasis was conducted. Results: We identified five cases of MCC with thyroid metastasis. Primary sites included the distal upper and lower extremities, axilla, buttock, and groin. Treatment courses varied including thyroidectomy, immunotherapy, and expectant palliative measures. Time from initial diagnosis to thyroid metastasis ranged from four months to four years. Tissue diagnosis was achieved in 5 of 6 cases. Conclusions: MCC with thyroid metastasis is rare and likely represents aggressive disease. Despite advances in treatment and surveillance, outcomes for MCC remain poor. Ongoing research may establish predictors for treatment response.
AB - Background: Merkel cell carcinoma (MCC) is an aggressive and rare neuroendocrine tumor, accounting for less than 1% of skin cancers. Metastasis primarily manifests in the cervical lymph nodes but rarely affect the thyroid. Methods: We report a case of primary head and neck cutaneous MCC with metastasis to the thyroid gland. A review of the literature of MCC with thyroid metastasis was conducted. Results: We identified five cases of MCC with thyroid metastasis. Primary sites included the distal upper and lower extremities, axilla, buttock, and groin. Treatment courses varied including thyroidectomy, immunotherapy, and expectant palliative measures. Time from initial diagnosis to thyroid metastasis ranged from four months to four years. Tissue diagnosis was achieved in 5 of 6 cases. Conclusions: MCC with thyroid metastasis is rare and likely represents aggressive disease. Despite advances in treatment and surveillance, outcomes for MCC remain poor. Ongoing research may establish predictors for treatment response.
KW - Merkel cell carcinoma
KW - Metastasis
KW - Thyroid cancer
UR - http://www.scopus.com/inward/record.url?scp=85189906926&partnerID=8YFLogxK
U2 - 10.1016/j.amjoto.2024.104278
DO - 10.1016/j.amjoto.2024.104278
M3 - Review article
AN - SCOPUS:85189906926
SN - 0196-0709
VL - 45
JO - American Journal of Otolaryngology - Head and Neck Medicine and Surgery
JF - American Journal of Otolaryngology - Head and Neck Medicine and Surgery
IS - 4
M1 - 104278
ER -